VIATRIS INC. for VIATRIS INC
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report (this page) | Jul 19, 2013 | $270,000 | Replaced |
| 2nd Quarter - Amendment | Jan 20, 2014 | $320,000 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
Patent Settlements
| Lobbyist | Covered position, as disclosed |
|---|---|
| NIMISH SHAH | — |
Health Issues HCR
Pharmaceutical Distribution Supply Chain Security, Electronic distribution of prescribing information, H.R. 2094, the School Access to Emergency Epinephrine Act, S.214, Preserve Access to Affordable Generics Act, S.504, Fair and Immediate Release of Generic Drugs ActH.R.460 - Patients' Access to Treatments Act of 2013, Generic Drug User Fees, Biosimilar User Fees, Compounding, S. 959: Pharmaceutical Compounding Quality and Accountability Act, H.R. 1919: Safeguarding Americas Pharmaceuticals Act of 2013, S.957, the Drug Supply Chain Security Act, Global HIV/AIDS programs
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL LUBOWITZ | — |
| NIMISH SHAH | — |
| KIMBERLEE TRZECIAK New | Legislative Director, Rep. Dingell |
Budget/Appropriations BUD
Global Health Appropriations, Presidents Emergency Plan for AIDS Relief, the Global Fund, FY 2014 Budget, FY 2013 Budget, Funding for FDA, Funding for the Office of Generic Drugs, FY14 Presidential Budget Request
| Lobbyist | Covered position, as disclosed |
|---|---|
| NIMISH SHAH | — |
| KIMBERLEE TRZECIAK New | Legislative Director, Rep. Dingell |
Support LegiList
This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.